Related Experiment Videos
Total body digoxin clearance and steady-state concentrations in low birth weight infants
Insights
Low birth weight infants require lower digoxin doses. Total body digoxin clearance (TBDC) in these infants depends on gestational age and weight, necessitating dose adjustments proportional to these factors.
Area of Science:
- Neonatal pharmacology
- Pediatric pharmacokinetics
Background:
- Digoxin is commonly used for heart conditions in infants.
- Low birth weight infants may metabolize drugs differently, affecting dosage requirements.
Purpose of the Study:
- To determine the relationship between digoxin pharmacokinetics and infant characteristics.
- To provide evidence-based recommendations for digoxin dosing in low birth weight infants.
Main Methods:
- Serial serum digoxin concentrations were measured over 10 days in 15 low birth weight infants.
- Total body digoxin clearance (TBDC) was calculated.
- Dose-normalized, steady-state digoxin concentrations were analyzed.
Main Results:
- Total body digoxin clearance (TBDC) was significantly influenced by gestational age and body weight.
- Higher gestational age and body weight correlated with increased TBDC.
- Dose-normalized digoxin concentrations were inversely related to gestational age and body weight.
Conclusions:
- Low birth weight infants exhibit decreased TBDC, supporting reduced digoxin maintenance doses.
- Digoxin dose reduction in these infants should be proportional to both gestational age and body weight.
- This study refines digoxin dosing guidelines for vulnerable neonatal populations.
Abstract:
Serial serum digoxin concentrations were measured over a 10-day period in 15 low birth weight infants requiring digoxin therapy. The calculated total body digoxin clearance (TBDC) was found to be highly dependent on gestational age and body weight, with dose-normalized, steady-state digoxin concentrations inversely related to the same factors. Because of the decreased TBDC in low birth weight infants, our data support the recent recommendations in the literature to reduce maintenance doses of digoxin in these infants. Our study has further demonstrated that the reduction should be proportional to both gestational age and body weight.